Original Research | ||||||||||||||||||||||||||||||
Evaluation of efficacy and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris A randomized controlled trial Meghana D, Laxminarayana Kamath, Revathi T N.
|
How to Cite this Article |
Pubmed Style D M, Kamath L, N RT. Evaluation of efficacy and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris A randomized controlled trial. Natl J Physiol Pharm Pharmacol. 2021; 11(1): 13-16. doi:10.5455/njppp.2021.10.07180202022082020 Web Style D M, Kamath L, N RT. Evaluation of efficacy and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris A randomized controlled trial. https://www.njppp.com/?mno=96512 [Access: December 03, 2023]. doi:10.5455/njppp.2021.10.07180202022082020 AMA (American Medical Association) Style D M, Kamath L, N RT. Evaluation of efficacy and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris A randomized controlled trial. Natl J Physiol Pharm Pharmacol. 2021; 11(1): 13-16. doi:10.5455/njppp.2021.10.07180202022082020 Vancouver/ICMJE Style D M, Kamath L, N RT. Evaluation of efficacy and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris A randomized controlled trial. Natl J Physiol Pharm Pharmacol. (2021), [cited December 03, 2023]; 11(1): 13-16. doi:10.5455/njppp.2021.10.07180202022082020 Harvard Style D, M., Kamath, . L. & N, . R. T. (2021) Evaluation of efficacy and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris A randomized controlled trial. Natl J Physiol Pharm Pharmacol, 11 (1), 13-16. doi:10.5455/njppp.2021.10.07180202022082020 Turabian Style D, Meghana, Laxminarayana Kamath, and Revathi T N. 2021. Evaluation of efficacy and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris A randomized controlled trial. National Journal of Physiology, Pharmacy and Pharmacology, 11 (1), 13-16. doi:10.5455/njppp.2021.10.07180202022082020 Chicago Style D, Meghana, Laxminarayana Kamath, and Revathi T N. "Evaluation of efficacy and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris A randomized controlled trial." National Journal of Physiology, Pharmacy and Pharmacology 11 (2021), 13-16. doi:10.5455/njppp.2021.10.07180202022082020 MLA (The Modern Language Association) Style D, Meghana, Laxminarayana Kamath, and Revathi T N. "Evaluation of efficacy and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris A randomized controlled trial." National Journal of Physiology, Pharmacy and Pharmacology 11.1 (2021), 13-16. Print. doi:10.5455/njppp.2021.10.07180202022082020 APA (American Psychological Association) Style D, M., Kamath, . L. & N, . R. T. (2021) Evaluation of efficacy and safety of topical 1% terbinafine versus topical 2% sertaconazole in patients with tinea cruris A randomized controlled trial. National Journal of Physiology, Pharmacy and Pharmacology, 11 (1), 13-16. doi:10.5455/njppp.2021.10.07180202022082020 |